Adherence to Dipeptidyl Peptidase‐4 Inhibitor Therapy among Type 2 Diabetes Patients with Employer‐Sponsored Health Insurance in Japan

Karen Kurtyka,Rie Nishikino,Chie Ito,Kim Brodovicz,Yong Chen,Kaan Tunceli

Adherence to Dipeptidyl Peptidase‐4 Inhibitor Therapy among Type 2 Diabetes Patients with Employer‐Sponsored Health Insurance in Japan

2016

Karen Kurtyka
Rie Nishikino
Chie Ito
Kim Brodovicz
Yong Chen
Kaan Tunceli

Aims/Introduction Dipeptidyl peptidase‐4 inhibitors (DPP‐4i) are a common first‐line treatment for type 2 diabetes in Japan. However, little is known about patients’ medication adherence, persistence and discontinuation in this setting.

Keywords:

Endocrinology
Dipeptidyl-Peptidase IV Inhibitors
Diabetes mellitus
Type 2 diabetes
Internal medicine
Discontinuation
Surgery
Dipeptidyl peptidase-4 inhibitor
Medicine
medication adherence
Physical therapy
health insurance

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations